-
Accutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024
01 Jun 2024 12:28 GMT
… exploratory objectives include pharmacokinetics, preliminary efficacy and pharmacodynamic evaluation. The study … ., Chief Executive Officer of Accutar Biotechnology, Inc. "We look … www.clinicaltrials.gov.
About Accutar Biotechnology, Inc.
Accutar is a …
-
Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer
01 Jun 2024 12:00 GMT
… (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) ( … successfully develop and commercialize our pharmaceutical products; the expense, length, … any other applicable regulator of pharmaceutical products; the regulatory environment …
-
Willow Biosciences announces licensing partnership with Laurus Labs for production of high─value active pharmaceutical ingredients
01 Jun 2024 06:06 GMT
… Biosciences Inc, a leading biotechnology company focused on revolutionizing industrial … ), a leading research-driven pharmaceutical and biotechnology company with a $3. … -value advanced intermediates and active pharmaceutical ingredients, including Willow…
-
4 Biotech Stocks Ready to Surge in June
31 May 2024 22:17 GMT
… biotech stocks Innoviva, Inc. (INVA), Halozyme Therapeutics, Inc. (HALO), Jazz Pharmaceuticals … plc (JAZZ), and Entrada Therapeutics, Inc. (TRDA).
The global biotech … , develops, and commercializes pharmaceutical products for unmet medical …
-
May Wrap Up - Tech And Biotech Stocks To Watch (CSE: CYBT) (TSX: SFTC) (TSX: ADCO) (NASDAQ: JAGX)
31 May 2024 20:23 GMT
… while the latest biotech company is a Pharmaceutical firm creating plant-derived … Biotech Directories :
Jaguar Health, Inc . (NASDAQ:JAGX ) is a commercial stage pharmaceuticals … pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing …
-
US lawmakers ask FBI for briefing on GenScript Biotech's links to China
31 May 2024 19:21 GMT
… the letter are Bestzyme, Legend Biotech and ProBio.
Drugmaker Legend partnered … other subsidiaries. GenScript is a pharmaceutical research and manufacturing service provider … Complete Genomics, and other possible biotech companies of concern.
The bill …
-
Bexion Pharmaceuticals, Inc. to Present at BIO International Convention 2024
31 May 2024 17:04 GMT
… will present at the 2024 Biotechnology Innovation Organization (BIO) … frontiers, the business of biotech, regulatory and policy outlooks, … peripheral neuropathy.
About Bexion Pharmaceuticals
Bexion Pharmaceuticals, a clinical-stage biopharmaceutical …
-
Global Pharmaceutical Industry Outlook 2024: Growing Competitive Intensity is Driving Pharma Digitization and Building Unique Growth Opportunities - ResearchAndMarkets.com
31 May 2024 16:46 GMT
… .
Other information covered include:
Pharmaceutical industry overview
Revenue forecasts by … affecting returns on investment. Pharmaceutical companies will continue to shift … Target Undruggable Proteins with Emerging Biotech Platforms
Growth Opportunity 3: …
-
3 Biotech Stocks Under $20 Worth Watching in June
31 May 2024 16:17 GMT
… , investors could consider fundamentally sound biotech stocks Equillium, Inc. (EQ), … 12.5%. Rising investments by pharmaceutical companies, government initiatives, and … the White House recently advanced biotechnology and biomanufacturing leadership with the …
-
Analyst Expectations For Vertex Pharmaceuticals's Future
31 May 2024 15:35 GMT
… the Story Behind Vertex Pharmaceuticals
Vertex Pharmaceuticals is a global biotechnology company that discovers … Return on Assets (ROA): Vertex Pharmaceuticals';s ROA lags behind … performance.
Debt Management: Vertex Pharmaceuticals';s debt-to-equity …